GOVXGeoVax Labs, Inc.

GOVX Stock Price, Valuation & Chart | GeoVax Labs, Inc.

Compare

$0.550-0.05 (-8.77%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology GOVX intrinsic value GOVX calculated fair value vs price

Overview Financials Dividends Ratios

GOVX Historical price chart

GOVX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization4.07M

PE Ratio-0.04

EPS-13.01

Trading Volume370.79K

Today's High/Low0.61/0.55

Dividend Yield0.00

52 Week High/Low19.2/0.55

Shares Outstanding7.37M

GOVX Financial Statement

GOVX Analyst ratings

GOVX Analysis & performance metrics

GOVX Company profile

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara…

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan,…

GOVX Management team

Name

Position

Harriet Latham Robinson Ph.D.

Founder, Chief Scientific Officer Emeritus & Member of Scientific Advisory Board

Mark W. Reynolds CPACFO

Chief Financial Officer & Corporate Secretary

Thomas O'Brien

Vice President of Quality Systems & Compliance

John W. Sharkey Ph.D.

Vice President of Business Development

Kelly T. McKee Jr., M.D., M.P.H.

Chief Medical Officer

Jeffrey Welch

Head of Process Development & Manufacturing Operations

David Alan DoddCEO

Chairman, President & Chief Executive Officer

Mark J. Newman Ph.D.

Chief Scientific Officer

Name

Position

Harriet Latham Robinson Ph.D.

Founder, Chief Scientific Officer Emeritus & Member of Scientific Advisory Board

Mark W. Reynolds CPACFO

Chief Financial Officer & Corporate Secretary

Thomas O'Brien

Vice President of Quality Systems & Compliance

John W. Sharkey Ph.D.

Vice President of Business Development

Kelly T. McKee Jr., M.D., M.P.H.

Chief Medical Officer

Jeffrey Welch

Head of Process Development & Manufacturing Operations

David Alan DoddCEO

Chairman, President & Chief Executive Officer

Mark J. Newman Ph.D.

Chief Scientific Officer

Management Team

Harriet Latham Robinson Ph.D.

Founder, Chief Scientific Officer Emeritus & Member of Scientific Advisory Board

Mark W. Reynolds CPACFO

Chief Financial Officer & Corporate Secretary

Thomas O'Brien

Vice President of Quality Systems & Compliance

John W. Sharkey Ph.D.

Vice President of Business Development

Kelly T. McKee Jr., M.D., M.P.H.

Chief Medical Officer

Jeffrey Welch

Head of Process Development & Manufacturing Operations

David Alan DoddCEO

Chairman, President & Chief Executive Officer

Mark J. Newman Ph.D.

Chief Scientific Officer

Management

Harriet Latham Robinson Ph.D.

Founder, Chief Scientific Officer Emeritus & Member of Scientific Advisory Board

Mark W. Reynolds CPACFO

Chief Financial Officer & Corporate Secretary

Thomas O'Brien

Vice President of Quality Systems & Compliance

John W. Sharkey Ph.D.

Vice President of Business Development

Kelly T. McKee Jr., M.D., M.P.H.

Chief Medical Officer

Jeffrey Welch

Head of Process Development & Manufacturing Operations

David Alan DoddCEO

Chairman, President & Chief Executive Officer

Mark J. Newman Ph.D.

Chief Scientific Officer

Total 8 executives

GOVX Frequently asked questions

What is GeoVax Labs, Inc. (GOVX) Stock Price?

Current stock price of GeoVax Labs, Inc. (GOVX) stock is $0.550. The stock price is -8.77% lower in the session. The intraday range can be seen from this page. Volume of GeoVax Labs, Inc. (GOVX) stock is 370.79K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the GeoVax Labs, Inc. (GOVX) stock price going up or down today?

The stock price of GeoVax Labs, Inc. (GOVX) can change with earnings, company news, and overall market sentiment. GeoVax Labs, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the GeoVax Labs, Inc. stock expensive at its current price?

Whether GeoVax Labs, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for GOVX on this page is -0.04. EPS on this page is -13.01. Compare those figures with peers and growth expectations before deciding if the current GeoVax Labs, Inc. price is justified.

How has the stock price of GeoVax Labs, Inc. (GOVX) performed historically?

Historical performance for GeoVax Labs, Inc. (GOVX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how GOVX reacted to past earnings and market events.

Should I buy GeoVax Labs, Inc. (GOVX) stock, at this price?

Buying GeoVax Labs, Inc. (GOVX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.